CLINICAL_TRIALS
trial_result
· 2022-11-29
Clinical Trial Update: A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes. [Phase 2]
Summary
A Phase 2 trial evaluating different doses of BI 456906 for adults with type 2 diabetes has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2022-11-29